Protalix BioTherapeutics DSO Ratio 2011-2026 | PLX

Annual DSO Ratio Protalix BioTherapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
40.7	28	27.5	30.8	25.9	19.4	31.4	50.4	32.6	27.5	-	45.4	66.3	15	227

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
227	15	47.7

Quarterly DSO Ratio Protalix BioTherapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
61	41.1	31	31.3	-	-	57.3	6.96	28	-	34.3	41.3	26.5	-	29.9	49.2	26.6	-	16.9	16.6	14.1	-	30.1	35	41.2	-	651	215	64.6	-	20.9	24.7	38.1	-	13.5	35.8	46.6	-	156	62	99.8	-	73.8	70.9	27.1	-	83.5	84.3	44.8	-	34.5	4.93	32.9	-	111	164	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
651	4.93	66.1

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Benitec Biopharma BNTC	141	$ 10.98	-4.52 %	$ 452 M	USA
Ascendis Pharma A/S ASND	132	$ 221.88	-0.87 %	$ 5 B	Danmark
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Assembly Biosciences ASMB	25.1	$ 28.46	3.45 %	$ 319 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Axsome Therapeutics AXSM	105	$ 156.92	-1.23 %	$ 7.81 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
AbCellera Biologics ABCL	173	$ 3.4	-3.68 %	$ 1.02 B	Canada
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
BioMarin Pharmaceutical BMRN	88.9	$ 54.13	-1.64 %	$ 10.4 B	USA
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Compugen Ltd. CGEN	60.8	$ 2.09	-0.95 %	$ 195 M	Israel
Coherus BioSciences CHRS	559	$ 1.52	-5.59 %	$ 178 M	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Corbus Pharmaceuticals Holdings CRBP	239	$ 8.6	-3.8 %	$ 115 M	USA
Curis CRIS	103	$ 0.77	1.89 %	$ 4.86 M	USA